Colorectal cancer screening in the COVID-19 era.
World J Gastrointest Oncol
; 13(4): 238-251, 2021 Apr 15.
Article
in English
| MEDLINE | ID: covidwho-1314849
ABSTRACT
Colorectal cancer (CRC) is the third most diagnosed form of cancer and second most deadly cancer worldwide. Introduction of better screening has improved both incidence and mortality. However, as the coronavirus disease 2019 (COVID-19) pandemic began, healthcare resources were shunted away from cancer screening services resulting in a sharp decrease in CRC screening and a backlog of patients awaiting screening tests. This may have significant effects on CRC cancer mortality, as delayed screening may lead to advanced cancer at diagnosis. Strategies to overcome COVID-19 related disruption include utilizing stool-based cancer tests, developing screening protocols based on individual risk factors, expanding telehealth, and increasing open access colonoscopies. In this review, we will summarize the effects of COVID-19 on CRC screening, the potential long-outcomes, and ways to adapt CRC screening during this global pandemic.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Language:
English
Journal:
World J Gastrointest Oncol
Year:
2021
Document Type:
Article
Affiliation country:
WJGO.V13.I4.238
Similar
MEDLINE
...
LILACS
LIS